meglumine has been researched along with Heart Failure in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (72.73) | 24.3611 |
| 2020's | 3 (27.27) | 2.80 |
| Authors | Studies |
|---|---|
| Bogaert, J; Degtiarova, G; Dresselaers, T; Flamée, L; Gheysens, O; Symons, R; Van Cleemput, J; Wuyts, W | 1 |
| Cluzel, P; Giron, A; Huber, AT; Kachenoura, N; Lamy, J; Razakamanantsoa, L; Redheuil, A | 1 |
| Bonnet, G; Champagne, S; Claude Morice, M; Garot, J; Garot, P; Hovasse, T; Kinnel, M; Landon, V; Louvard, Y; Pezel, T; Sanguineti, F; Unterseeh, T | 1 |
| Arnold, JR; Gulsin, GS; Khoo, J; Lai, FY; Levelt, E; McCann, GP; Shetye, A; Squire, IB; Swarbrick, DJ | 1 |
| Adam, G; Avanesov, M; Blankenberg, S; Bohnen, S; Cavus, E; Jagodzinski, A; Karakas, M; Lund, GK; Muellerleile, K; Ojeda, F; Radunski, UK; Schnabel, RB; Schneider, J; Spink, C; Tahir, E; Zeller, T | 1 |
| Hänninen, H; Holmström, M; Kivistö, S; Pöyhönen, P | 1 |
| Chistyakov, IS; Medvedev, AP; Pichugin, VV | 1 |
| Danton, MH; Dobson, RJ; Mordi, I; Tzemos, N; Walker, HA; Walker, NL | 1 |
| Antonaci, S; Baiardi, P; Baldi, M; Catalano, O; Ceresa, M; Frascaroli, M; Moro, G; Napolitano, C; Perotti, M; Priori, SG | 1 |
| America, YG; Braam, B; Cramer, MJ; de Vries, JJ; Doevendans, PA; Emans, ME; Gaillard, CA; Hillege, HL; Meiss, L; van der Putten, K; Velthuis, BK | 1 |
| Bluemke, DA; Han, J; Jones, J; Kawel, N; Kellman, P; Liu, S; Nacif, MS; Sibley, CT | 1 |
1 trial(s) available for meglumine and Heart Failure
| Article | Year |
|---|---|
Atherosclerotic renal artery stenosis is prevalent in cardiorenal patients but not associated with left ventricular function and myocardial fibrosis as assessed by cardiac magnetic resonance imaging.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Atherosclerosis; Cardio-Renal Syndrome; Chi-Square Distribution; Contrast Media; Erythropoietin; Female; Fibrosis; Glomerular Filtration Rate; Heart Failure; Hematinics; Humans; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Myocardium; Netherlands; Organometallic Compounds; Predictive Value of Tests; Prevalence; Prognosis; Renal Artery; Renal Artery Obstruction; Renal Insufficiency, Chronic; Risk Assessment; Risk Factors; Severity of Illness Index; Stroke Volume; Ventricular Function, Left | 2012 |
10 other study(ies) available for meglumine and Heart Failure
| Article | Year |
|---|---|
Prognostic value of cardiovascular magnetic resonance in patients with biopsy-proven systemic sarcoidosis.
Topics: Adult; Biopsy; Cardiomyopathies; Contrast Media; Defibrillators, Implantable; Electric Countershock; Female; Gadolinium DTPA; Heart; Heart Arrest; Heart Failure; Heart Ventricles; Hospitalization; Humans; Magnetic Resonance Imaging; Magnetic Resonance Imaging, Cine; Male; Meglumine; Middle Aged; Mortality; Myocardium; Organometallic Compounds; Prognosis; Prospective Studies; Risk Assessment; Sarcoidosis; Severity of Illness Index; Tachycardia, Ventricular; Ventricular Fibrillation | 2020 |
Multiparametric Differentiation of Idiopathic Dilated Cardiomyopathy With and Without Congestive Heart Failure by Means of Cardiac and Hepatic T1-Weighted MRI Mapping.
Topics: Cardiomyopathy, Dilated; Case-Control Studies; Contrast Media; Cross-Sectional Studies; Diagnosis, Differential; Female; Heart Failure; Heart Function Tests; Humans; Liver; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies | 2020 |
Safety and Prognostic Value of Vasodilator Stress Cardiovascular Magnetic Resonance in Patients With Heart Failure and Reduced Ejection Fraction.
Topics: Aged; Contrast Media; Dipyridamole; Female; Heart Failure; Humans; Infusions, Intravenous; Longitudinal Studies; Magnetic Resonance Imaging, Cine; Male; Meglumine; Middle Aged; Myocardial Infarction; Myocardial Perfusion Imaging; Organometallic Compounds; Predictive Value of Tests; Prognosis; Retrospective Studies; Risk Assessment; Risk Factors; Stroke Volume; Time Factors; Vasodilator Agents; Ventricular Function, Left | 2020 |
Does stress perfusion imaging improve the diagnostic accuracy of late gadolinium enhanced cardiac magnetic resonance for establishing the etiology of heart failure?
Topics: Adenosine; Aged; Aged, 80 and over; Cardiomyopathies; Contrast Media; Coronary Angiography; Diagnosis, Differential; Female; Heart Failure; Humans; Magnetic Resonance Imaging, Cine; Male; Meglumine; Middle Aged; Myocardial Ischemia; Myocardial Perfusion Imaging; Organometallic Compounds; Predictive Value of Tests; Retrospective Studies; Risk Factors; Vasodilator Agents; Ventricular Dysfunction, Left; Ventricular Function, Left | 2017 |
Cardiovascular magnetic resonance imaging in the prospective, population-based, Hamburg City Health cohort study: objectives and design.
Topics: Aged; Atrial Fibrillation; Contrast Media; Coronary Artery Disease; Female; Follow-Up Studies; Germany; Heart Failure; Humans; Incidence; Magnetic Resonance Imaging, Cine; Male; Meglumine; Middle Aged; Organometallic Compounds; Pilot Projects; Predictive Value of Tests; Prognosis; Prospective Studies; Reproducibility of Results; Research Design; Time Factors; Workflow | 2018 |
Quantifying late gadolinium enhancement on CMR provides additional prognostic information in early risk-stratification of nonischemic cardiomyopathy: a cohort study.
Topics: Adult; Arrhythmias, Cardiac; Cardiomyopathies; Contrast Media; Diagnosis, Differential; Female; Heart Failure; Heart Ventricles; Humans; Magnetic Resonance Imaging, Cine; Male; Meglumine; Middle Aged; Organometallic Compounds; Predictive Value of Tests; Prognosis; Retrospective Studies; Risk Factors; Stroke Volume; Ventricular Function, Left | 2014 |
[Optimization of postoperative medical therapy of infective endocarditis in patients with congenital valvular heart disease].
Topics: Adolescent; Adult; Antioxidants; Creatine Kinase; Endocarditis; Female; Heart Failure; Heart Valve Diseases; Heart Valve Prosthesis Implantation; Humans; Infusions, Intravenous; Male; Meglumine; Metabolic Diseases; Middle Aged; Postoperative Complications; Succinates; Treatment Outcome | 2016 |
Late gadolinium enhancement and adverse outcomes in a contemporary cohort of adult survivors of tetralogy of Fallot.
Topics: Adolescent; Adult; Arrhythmias, Cardiac; Cardiac Surgical Procedures; Contrast Media; Defibrillators, Implantable; Electric Countershock; Female; Fibrosis; Follow-Up Studies; Heart Failure; Heart Ventricles; Hospitalization; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Myocardium; Organometallic Compounds; Predictive Value of Tests; Prospective Studies; Risk Factors; Scotland; Survivors; Tertiary Care Centers; Tetralogy of Fallot; Time Factors; Treatment Outcome; Young Adult | 2017 |
Late gadolinium enhancement by cardiovascular magnetic resonance is complementary to left ventricle ejection fraction in predicting prognosis of patients with stable coronary artery disease.
Topics: Aged; Chi-Square Distribution; Contrast Media; Coronary Artery Disease; Disease-Free Survival; Female; Gadolinium DTPA; Heart Failure; Hospitalization; Humans; Italy; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Multivariate Analysis; Organometallic Compounds; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Prospective Studies; Risk Assessment; Risk Factors; Stroke Volume; Time Factors; Ventricular Function, Left | 2012 |
Diffuse myocardial fibrosis evaluation using cardiac magnetic resonance T1 mapping: sample size considerations for clinical trials.
Topics: Adult; Aged; Analysis of Variance; Case-Control Studies; Clinical Trials as Topic; Contrast Media; Female; Fibrosis; Heart Failure; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Myocardium; Organometallic Compounds; Predictive Value of Tests; Reproducibility of Results; Sample Size; Time Factors; Young Adult | 2012 |